Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Earwax Impaction Solution Now Available on Amazon

By Eosera | May 16, 2017

Fort Worth-based EOSERA™ Inc. announces the launch of their earwax removal product, Earwax MD™ with Amazon Exclusives. The product comes in two sizes, a kit that includes a 15mL bottle and rinsing bulb, and a single 15mL bottle only.

Amazon Exclusives features products only sold on Amazon.com and the brand’s website, and will be the first to carry Earwax MD. Amazon Exclusives features new and innovative items including products featured on the show “Shark Tank.”

Earwax MD is available on Amazon.com with free shipping for Prime customers.

Eosera decided that Amazon.com was the perfect place to sell their first product, Earwax MD. After decades of unsuccessful attempts by other manufacturers, Earwax MD is the first earwax impaction solution to safely and effectively dissolve wax blockage in a single application.

“When I met with Amazon, we decided it would be wonderful to launch with them because they reach all consumers,” said Elyse Dickerson, Founder & CEO of Eosera, Inc. “Our earwax solution will help people worldwide and Amazon is the first step. By bringing this novel innovation to market, our goal is to improve the lives of both doctors and patients by saving people time and money.”

Patients can now proactively clean their ears at home, which means fewer visits to the doctor for earwax removal. Dickerson advises patients to visit www.earwaxmd.com for explanatory videos on how to use Earwax MD.

“Instead of having to dig out earwax, audiologists and hearing aid centers can now fit patients for hearing aids in one visit,” she said. Healthcare professionals can purchase Earwax MD as a medical supply from select distributors.

A Clinically Proven Impaction Solution

In a clinical evaluation of Earwax MD, a total of 30 ears with moderate to severe earwax impaction were tested. A single application of Earwax MD (consisting of up to two doses) not only fully cleared the impaction in 86 percebt of test subjects but also reduced symptoms by a remarkable 82 percent.

Common symptoms of earwax impaction include a feeling of fullness, itching, ringing of the ears, and hearing loss.

In a separate study, researchers compared Earwax MD to Murine Ear* and  Debrox*. The researchers collected samples of human earwax, placed them in test tubes with each solution, and measured the solutions’ effectiveness at dissolving the wax. Using a scale of 0 (no disintegration) to 4 (complete disintegration), wax samples were evaluated and scored at 5, 10, 15, and 30 minutes. At the end of 30 minutes, Earwax MD showed significant disintegration of the wax samples (scored 3.24), while Murine Ear and Debrox barely showed any change in the wax samples (scored 0.12).

Safe for Human Skin

Eosera also worked with a dermatologist to ensure Earwax MD was safe on skin. Fifty subjects were exposed to Earwax MD in a series of tests designed to evaluate product safety. Skin tests showed absolutely no evidence of irritation. 

About EOSERA/Earwax MD 

EOSERA™, Inc. is a majority woman-owned biotech company committed to developing products that address underserved medical needs. Eosera operates by putting purpose before profits and is proud to be one of the pioneering companies in a movement called Conscious Capitalism. Eosera exists to heal hu­mans through innovative healthcare products.

Eosera’s first product, Earwax MD™, is a novel, patent-pending topical drop that uses a dual-action technology to dissolve impacted earwax. It is the first topical earwax treatment innovation in over 50 years. Earwax MD is clinically proven to perform in a single treatment, unlike alternatives that require multiple applications over time. Earwax MD is the only product on the market today that is supported by scientific efficacy.

For more information, visit  www.earwaxmd.com.

(Source: Eosera)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
This is the logo of Novartis.
Novartis opens new manufacturing plant in California
samsung biologics (1)
Samsung Biologics completes Bioepis spinoff to become pure-play pharma CDMO
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE